Truvestments Capital’s Palvella Therapeutics PVLA Stock Holding History

Truvestments Capital’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.75K	Hold	14	–	–	﹤0.01%	1014
2025 Q4	$1.47K	Hold	14	–	–	﹤0.01%	900
2025 Q3	$878	Hold	14	–	–	﹤0.01%	955
2025 Q2	$316	Hold	14	–	–	﹤0.01%	914
2025 Q1	$392	Hold	14	–	–	﹤0.01%	971
2024 Q4	$168	Hold	14	–	–	﹤0.01%	977
2024 Q3	$232	Buy	+14	New	+$205	﹤0.01%	898
2024 Q2	–	Sell	-14	Closed	-$205	–	713
2024 Q1	$205	Hold	14	–	–	﹤0.01%	700
2023 Q4	$204	Hold	14	–	–	﹤0.01%	769
2023 Q3	$334	Hold	14	–	–	﹤0.01%	656
2023 Q2	$185	Hold	14	–	–	﹤0.01%	674
2023 Q1	$1.09K	Sell	14 -10	-42%	-$1.16K	﹤0.01%	603
2022 Q4	$2K	Hold	24	–	–	﹤0.01%	721
2022 Q3	$2K	Sell	24 -3	-11%	-$387	﹤0.01%	577
2022 Q2	$4K	Buy	+27	New	+$4.93K	﹤0.01%	516
2022 Q1	–	Sell	-17	Closed	-$5K	–	576
2021 Q4	$5K	Hold	17	–	–	﹤0.01%	497
2021 Q3	$7K	Hold	17	–	–	﹤0.01%	426
2021 Q2	$5K	Hold	17	–	–	﹤0.01%	469
2021 Q1	$3K	Buy	17 +8	+89%	+$1.75K	﹤0.01%	590
2020 Q4	$1K	Buy	+9	New	+$1.87K	﹤0.01%	596
2020 Q3	–	Sell	-9	Closed	-$2K	–	575
2020 Q2	$2K	Buy	+9	New	+$2.1K	﹤0.01%	523
2019 Q4	–	Sell	-16	Closed	-$4K	–	625
2019 Q3	$4K	Sell	16 -2	-11%	-$774	﹤0.01%	614
2019 Q2	$7K	Hold	18	–	–	﹤0.01%	584
2019 Q1	$5K	Buy	+18	New	+$4.28K	﹤0.01%	611
2018 Q3	$8K	Buy	+19	New	+$8.26K	﹤0.01%	689

Other funds holding PVLA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Truvestments Capital's PVLA Position: Q1 2026 in Review

Truvestments Capital held its Palvella Therapeutics (PVLA) position steady in Q1 2026 at 14 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Truvestments Capital first reported a position in PVLA in Q3 2018 and has held it in 25 quarters since. The position peaked at $8K in Q3 2018. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

Truvestments Capital held 14 shares of Palvella Therapeutics worth $1.75K as of Q1 2026.
Truvestments Capital left its Palvella Therapeutics share count unchanged in Q1 2026.
Palvella Therapeutics made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1014 holding.
Truvestments Capital first reported a position in Palvella Therapeutics in Q3 2018 and has held it in 25 quarters since.
Truvestments Capital's Palvella Therapeutics position peaked at $8K in Q3 2018.
180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.